Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05008744 · ClinicalTrials.gov registry record
Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
A clinical trial of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 2
- Study locations
NCT05008744: Recruiting study of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition, sponsored by Seattle Children's Hospital.
NCT05008744 is a study of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 2,000 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05008744, a study of Monochorionic Diamniotic Placenta and Twin to Twin Transfusion as Antepartum Condition, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.
Primary Outcome
Survival to discharge from the nursery of affected babies
Conditions Studied
Interventions
- PROCEDURE Fetoscopic laser ablation
Study Locations (2)
Washington
- Seattle Childrens Hospital - Seattle
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2031-10-01 |
What NCT05008744 shows while recruiting
NCT05008744 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Monochorionic Diamniotic Placenta appearing as the primary indexed condition, and to 1 intervention - of which Fetoscopic laser ablation is the first listed.
NCT05008744 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05008744 about?
NCT05008744 is a clinical study titled "Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome". The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.
What is the current status of trial NCT05008744?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-10-01. Estimated completion is 2031-10-01.
What conditions does trial NCT05008744 study?
This clinical trial studies the following conditions: Monochorionic Diamniotic Placenta, Twin to Twin Transfusion as Antepartum Condition.
What interventions are being tested in trial NCT05008744?
The interventions under investigation include: Fetoscopic laser ablation (PROCEDURE).
Who is sponsoring clinical trial NCT05008744?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05008744 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Monochorionic Diamniotic Placenta
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI